Related Experiment Video
Updated: Oct 11, 2025

Author Spotlight: Advancements in Multiplex Detection of Respiratory Viruses
Published on: November 10, 2023
[Epidemiology, clinical characteristics and treatment in 278 patients with coronavirus disease 2019 in Guangzhou]
1Department of Emergency, Guangzhou Eighth People's Hospital, Guangzhou 510060, China.
Insights
This study analyzed 278 coronavirus disease 2019 (COVID-19) patients, finding common symptoms like fever and cough, with a low in-hospital mortality rate of 0.4%. Most cases were imported, highlighting the need for attention to disease progression.
Area of Science:
- Infectious Diseases
- Epidemiology
- Pulmonology
Background:
- Coronavirus disease 2019 (COVID-19) emerged as a global pandemic.
- Understanding the epidemiology and clinical spectrum is crucial for patient management.
Purpose of the Study:
- To retrospectively analyze the epidemiology, clinical characteristics, treatment, and prognosis of COVID-19 patients.
- To identify key indicators for disease progression and outcomes.
Main Methods:
- Retrospective analysis of 278 COVID-19 patients admitted to Guangzhou Eighth People's Hospital.
- Data collected included demographics, epidemiology, clinical symptoms, laboratory tests, CT imaging, treatment, and prognosis.
Main Results:
- The study included patients aged 20-69 years, with 84.9% having comorbidities and 75.9% presenting as common type.
- Fever (70.9%) and dry cough (61.5%) were most common; elevated LDH, creatine kinase, prolonged APTT, D-dimer, and CRP were observed.
- CT findings showed ground glass shadows, consolidation, and "white lung" in severe cases; in-hospital mortality was 0.4%.
Conclusions:
- COVID-19 affects all age groups, predominantly presenting as a common type with low mortality.
- Clinical manifestations can involve multiple organs, and disease progression requires close monitoring.
- Treatment involved antiviral agents, antibacterials, oxygen therapy, and traditional Chinese medicine.
Abstract:
Objective: To retrospective analyze the epidemiology, clinical characteristics, treatment and prognosis in patients with coronavirus disease 2019 (COVID-19). Methods: A total of 278 patients with COVID-19 admitted to Guangzhou Eighth People's Hospital from January 20 to February 10, 2020 were selected. The general demographic data, epidemiological data, clinical symptoms, laboratory examinations, lung CT imaging, treatment and prognosis were analyzed. Results: There were 130 male patients (46.8%) and 148 females (53.2%) with age (48.1±17.0) years and 88.8% patients between 20-69 years. Two hundred and thirty-six (84.9%) patients had comorbidities. Two hundred and eleven cases (75.9%) were common type. The in-hospital mortality was 0.4% (1/278). The majority (201, 72.3%) were imported cases mainly from Wuhan (89, 44.3%). The most common clinical manifestations were fever (70.9%) and dry cough (61.5%). In some patients, hemoglobin (10.4%), platelets (12.6%) and albumin (55.4%) were lower than the normal range. Other biochemical tests according to liver and function were normal, while lactic dehydrogenase (LDH) was elevated in 61 patients (21.9%), creatine kinase increased in 26 patients (9.4%). Prolonged activated partial thromboplastin time (APTT) was seen in 52 patients (18.7%), D-dimer higher than normal in 140 patients (50.4%), while 117 patients (42.1%) had elevated high-sensitivity C-reactive protein. Typical CT manifestations included single or multiple ground glass shadows especially in lung periphery in early disease which infiltrated and enlarged during progressive stage. Diffuse consolidation with multiple patchy density in severe/critical cases and even "white lung" presented in a few patients. Two hundred and forty-two patients (87.1%) received one or more antiviral agents, 242 (87.1%) combined with antibacterials, 191 (68.7%) with oxygen therapy. There were 198 patients (71.2%) treated with traditional Chinese medicine. Conclusions: COVID-19 could attack patients in all ages with majority of common type and low mortality rate. Clinical manifestations involve multiple organs or systems. Progression of the disease results in critical status which should be paid much attention.
More Related Videos
08:05Lung CT Segmentation to Identify Consolidations and Ground Glass Areas for Quantitative Assesment of SARS-CoV Pneumonia
Published on: December 19, 2020
09:03Nasal Brushing Sampling and Processing Using Digital High Speed Ciliary Videomicroscopy – Adaptation for the COVID-19 Pandemic
Published on: November 7, 2020
Related Concept Videos
Single Nucleotide Polymorphisms-SNPs
COPD: Pathogenesis and Clinical Features
The primary cause for the onset of COPD is cigarette smoking and exposure to air pollution. These hazardous factors initiate a chain reaction within the lungs, resulting in chronic inflammation, damage to the airways, and a...
Chronic Obstructive Pulmonary Disease-V: Management
Smoking Cessation
Gastroesophageal Reflux Disease II: Clinical Features and Management
Clinical Manifestations
GERD presents itself in a multitude of ways, with symptoms varying from person to person. The hallmark symptoms are...
Pulmonary Tuberculosis V
Latent tuberculosis infection occurs when TB bacteria are present in a person's body, but are not causing illness or symptoms. It is not contagious, and preventive treatment is crucial to avoid the...
Acute Pancreatitis II: Clinical Manifestations and Management